TEVA logo

TEVA Working capital

annual working capital:

-$244.00M-$482.00M(-202.52%)
December 31, 2024

Summary

  • As of today (May 30, 2025), TEVA annual working capital is -$244.00 million, with the most recent change of -$482.00 million (-202.52%) on December 31, 2024.
  • During the last 3 years, TEVA annual working capital has fallen by -$1.79 billion (-115.78%).
  • TEVA annual working capital is now -104.52% below its all-time high of $5.39 billion, reached on December 31, 2015.

Performance

TEVA Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly working capital:

$371.00M+$615.00M(+252.05%)
March 31, 2025

Summary

  • As of today (May 30, 2025), TEVA quarterly working capital is $371.00 million, with the most recent change of +$615.00 million (+252.05%) on March 31, 2025.
  • Over the past year, TEVA quarterly working capital has increased by +$1.87 billion (+124.82%).
  • TEVA quarterly working capital is now -94.07% below its all-time high of $6.26 billion, reached on June 30, 2010.

Performance

TEVA quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

TEVA Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-202.5%+124.8%
3 y3 years-115.8%-55.7%
5 y5 years-16.2%-34.0%

TEVA Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-115.8%at low-68.2%+124.8%
5 y5-year-115.8%at low-76.0%+124.8%
alltimeall time-104.5%+90.4%-94.1%+114.6%

TEVA Working capital History

DateAnnualQuarterly
Mar 2025
-
$371.00M(-252.0%)
Dec 2024
-$244.00M(-202.5%)
-$244.00M(-83.5%)
Sep 2024
-
-$1.48B(+5.6%)
Jun 2024
-
-$1.41B(-6.0%)
Mar 2024
-
-$1.50B(-728.2%)
Dec 2023
$238.00M(-59.1%)
$238.00M(+667.7%)
Sep 2023
-
$31.00M(-87.3%)
Jun 2023
-
$245.00M(-77.5%)
Mar 2023
-
$1.09B(+87.3%)
Dec 2022
$582.00M(-62.4%)
$582.00M(-818.5%)
Sep 2022
-
-$81.00M(-106.9%)
Jun 2022
-
$1.17B(+39.4%)
Mar 2022
-
$838.00M(-45.8%)
Dec 2021
$1.55B(-1072.3%)
$1.55B(+369.9%)
Sep 2021
-
$329.00M(+151.1%)
Jun 2021
-
$131.00M(-58.0%)
Mar 2021
-
$312.00M(-296.2%)
Dec 2020
-$159.00M(-24.3%)
-$159.00M(-378.9%)
Sep 2020
-
$57.00M(-94.5%)
Jun 2020
-
$1.03B(+83.3%)
Mar 2020
-
$562.00M(-367.6%)
Dec 2019
-$210.00M(-60.2%)
-$210.00M(-86.6%)
Sep 2019
-
-$1.56B(+141.9%)
Jun 2019
-
-$647.00M(+8.4%)
Mar 2019
-
-$597.00M(+13.1%)
Dec 2018
-$528.00M(-79.2%)
-$528.00M(-44.4%)
Sep 2018
-
-$949.00M(-291.3%)
Jun 2018
-
$496.00M(-818.8%)
Mar 2018
-
-$69.00M(-97.3%)
Dec 2017
-$2.54B(+101.5%)
-$2.54B(+254.1%)
Sep 2017
-
-$717.00M(-16.8%)
Jun 2017
-
-$862.00M(-19.3%)
Mar 2017
-
-$1.07B(-15.2%)
Dec 2016
-$1.26B(-123.4%)
-$1.26B(-33.7%)
Sep 2016
-
-$1.90B(-148.3%)
Jun 2016
-
$3.93B(-3.8%)
Mar 2016
-
$4.09B(-24.2%)
Dec 2015
$5.39B(+156.0%)
$5.39B(-1228.2%)
Sep 2015
-
-$478.00M(-59.3%)
Jun 2015
-
-$1.17B(-136.2%)
Mar 2015
-
$3.24B(+54.0%)
Dec 2014
$2.11B(+20.1%)
$2.11B(-6.5%)
Sep 2014
-
$2.25B(+33.2%)
Jun 2014
-
$1.69B(-17.3%)
Mar 2014
-
$2.05B(+16.6%)
Dec 2013
$1.75B(-49.4%)
$1.75B(+0.5%)
Sep 2013
-
$1.75B(+39.0%)
Jun 2013
-
$1.26B(-39.0%)
Mar 2013
-
$2.06B(-40.6%)
Dec 2012
$3.47B(+346.2%)
$3.47B(-20.4%)
Sep 2012
-
$4.36B(+3.3%)
Jun 2012
-
$4.22B(+214.9%)
Mar 2012
-
$1.34B(+72.5%)
Dec 2011
$777.00M(-66.9%)
$777.00M(-49.5%)
Sep 2011
-
$1.54B(-39.7%)
Jun 2011
-
$2.55B(-19.4%)
Mar 2011
-
$3.17B(+34.9%)
Dec 2010
$2.35B
$2.35B(-7.4%)
Sep 2010
-
$2.54B(-59.5%)
Jun 2010
-
$6.26B(+46.7%)
DateAnnualQuarterly
Mar 2010
-
$4.27B(-6.0%)
Dec 2009
$4.54B(+54.1%)
$4.54B(+7.4%)
Sep 2009
-
$4.22B(+11.3%)
Jun 2009
-
$3.79B(+47.7%)
Mar 2009
-
$2.57B(-12.7%)
Dec 2008
$2.94B(-34.4%)
$2.94B(-50.7%)
Sep 2008
-
$5.97B(+11.2%)
Jun 2008
-
$5.37B(+13.2%)
Mar 2008
-
$4.74B(+5.6%)
Dec 2007
$4.49B(+25.7%)
$4.49B(+14.7%)
Sep 2007
-
$3.91B(-0.5%)
Jun 2007
-
$3.94B(+16.4%)
Mar 2007
-
$3.38B(-5.3%)
Dec 2006
$3.57B(+10.0%)
$3.57B(+8.2%)
Sep 2006
-
$3.30B(+23.4%)
Jun 2006
-
$2.67B(+22.6%)
Mar 2006
-
$2.18B(-32.8%)
Dec 2005
$3.25B(+62.4%)
$3.25B(+45.3%)
Sep 2005
-
$2.23B(+2.7%)
Jun 2005
-
$2.17B(+5.7%)
Mar 2005
-
$2.06B(+3.0%)
Dec 2004
$2.00B(-1.2%)
$2.00B(-8.7%)
Sep 2004
-
$2.19B(+24.2%)
Jun 2004
-
$1.76B(+4.7%)
Mar 2004
-
$1.68B(-16.7%)
Dec 2003
$2.02B(+46.8%)
$2.02B(+79.4%)
Sep 2003
-
$1.13B(-23.5%)
Jun 2003
-
$1.47B(+3.2%)
Mar 2003
-
$1.43B(+3.6%)
Dec 2002
$1.38B(-4.3%)
$1.38B(+4.5%)
Sep 2002
-
$1.32B(+0.1%)
Jun 2002
-
$1.32B(-2.3%)
Mar 2002
-
$1.35B(-6.3%)
Dec 2001
$1.44B(+74.5%)
$1.44B(+2.3%)
Sep 2001
-
$1.41B(+55.5%)
Jun 2001
-
$905.41M(+4.1%)
Mar 2001
-
$870.12M(+5.5%)
Dec 2000
$825.09M(+120.9%)
$825.09M(+75.1%)
Sep 2000
-
$471.21M(+58.3%)
Jun 2000
-
$297.74M(-24.8%)
Mar 2000
-
$395.95M(+6.0%)
Dec 1999
$373.45M(+56.5%)
$373.45M(+41.6%)
Sep 1999
-
$263.70M(-12.8%)
Jun 1999
-
$302.50M(+14.3%)
Mar 1999
-
$264.60M(+10.9%)
Dec 1998
$238.60M(-1.1%)
$238.60M(+13.2%)
Sep 1998
-
$210.80M(-13.9%)
Jun 1998
-
$244.80M(+1.6%)
Mar 1998
-
$240.90M(-0.1%)
Dec 1997
$241.20M(+18.1%)
$241.20M(+18.1%)
Dec 1996
$204.20M(+88.6%)
$204.20M(+88.6%)
Dec 1995
$108.30M(-32.2%)
$108.30M(-32.2%)
Dec 1994
$159.80M(+29.3%)
$159.80M(+29.3%)
Dec 1993
$123.60M(+32.6%)
$123.60M(+32.6%)
Dec 1992
$93.20M(-10.6%)
$93.20M(-10.6%)
Dec 1991
$104.20M(+23.9%)
$104.20M(+23.9%)
Dec 1990
$84.10M(+9.5%)
$84.10M(+9.5%)
Dec 1989
$76.80M(+103.2%)
$76.80M(+103.2%)
Dec 1988
$37.80M(-6.4%)
$37.80M(-6.4%)
Mar 1987
$40.40M(-4.7%)
$40.40M(-4.7%)
Mar 1986
$42.40M
$42.40M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual working capital?
  • What is the all time high annual working capital for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual working capital year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly working capital?
  • What is the all time high quarterly working capital for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly working capital year-on-year change?

What is Teva Pharmaceutical Industries Limited annual working capital?

The current annual working capital of TEVA is -$244.00M

What is the all time high annual working capital for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual working capital is $5.39B

What is Teva Pharmaceutical Industries Limited annual working capital year-on-year change?

Over the past year, TEVA annual working capital has changed by -$482.00M (-202.52%)

What is Teva Pharmaceutical Industries Limited quarterly working capital?

The current quarterly working capital of TEVA is $371.00M

What is the all time high quarterly working capital for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly working capital is $6.26B

What is Teva Pharmaceutical Industries Limited quarterly working capital year-on-year change?

Over the past year, TEVA quarterly working capital has changed by +$1.87B (+124.82%)
On this page